000			01991 a2200529 4500
005			20250516144827.0
264		0	_c20140110
008			201401s 0 0 eng d
022			_a1582-4934
024	7		_a10.1111/jcmm.12046 _2doi
040			_aNLM _beng _cNLM
100	1		_aYi, Yong Weon
245	0	0	_aInhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells. _h[electronic resource]
260			_bJournal of cellular and molecular medicine _cMay 2013
300			_a648-56 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCaspases _xmetabolism
650	0	4	_aCell Death _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aDrug Synergism
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aExtracellular Signal-Regulated MAP Kinases _xmetabolism
650	0	4	_aFemale
650	0	4	_aFurans _xpharmacology
650	0	4	_aGefitinib
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors
650	0	4	_aPyridines _xpharmacology
650	0	4	_aPyrimidines _xpharmacology
650	0	4	_aQuinazolines _xpharmacology
650	0	4	_aSignal Transduction _xdrug effects
700	1		_aHong, Wooyoung
700	1		_aKang, Hyo Jin
700	1		_aKim, Hee Jeong
700	1		_aZhao, Wenjing
700	1		_aWang, Antai
700	1		_aSeong, Yeon-Sun
700	1		_aBae, Insoo
773	0		_tJournal of cellular and molecular medicine _gvol. 17 _gno. 5 _gp. 648-56
856	4	0	_uhttps://doi.org/10.1111/jcmm.12046 _zAvailable from publisher's website
999			_c22683772 _d22683772